Delivery Order SPE2DB20D2014-SPE2DB25FD07X
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,227.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order fulfillment. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,172.50 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens on September 9, 2025, with completion targeted for September 10, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a direct fulfillment of pharmaceutical supply needs for the Department of Defense. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,033.47 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with performance scheduled for completion by August 18, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,457.49 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery transaction under AmerisourceBergen's existing pharmaceutical supply framework. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,379.08 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL format) on August 5, 2025, with completion scheduled for August 6, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a small-value pharmaceutical procurement supporting military and federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,367.70 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens on September 11, 2025, with completion scheduled for September 12, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,505.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,022.80 to supply Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 29, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on May 30, 2025, with an ultimate completion date of June 2, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,534.20 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on June 26, 2025, with completion scheduled for June 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled at the company's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD07XDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens valued at $1,517.85, with completion expected by September 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across diverse therapeutic domains, from specialty medications to routine pharmaceutical products like insulin.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/23/25 |